One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use

Conclusion
The use of the nMARQ™ catheter is associated with important device-related limitations to achieve successful PVI. However, clinical outcomes were equivalent in nMARQ™- and SAC-treated patients.

Source: Europace - August 4, 2016 Category: Cardiology Authors: Wakili, R., Siebermair, J., Fichtner, S., Sinner, M. F., Klocker, E., Olesch, L., Hilberath, J. N., Sarai, S., Clauss, S., Sattler, S., Kääb, S., Estner, H. L. Tags: Ablation for atrial fibrillation Source Type: research